scholarly journals Adverse Reactions and Gastrointestinal Tract

10.5772/32353 ◽  
2012 ◽  
Author(s):  
A. Lorenzo ◽  
E. Ramirez ◽  
Jf. Snchez
Keyword(s):  
Gastrointestinal Tract ◽  
Adverse Reactions

scholarly journals The Application Effect of High Quality Nursing Service in the Painless Gastroscopy Examination

2013 ◽  
Vol 2 ◽  
pp. 6
Author(s):  
Jina Guo
Keyword(s):  
Blood Pressure ◽  
Gastrointestinal Tract ◽  
Reaction Rate ◽  
Adverse Reactions ◽  
High Quality ◽  
Nursing Service ◽  
Satisfaction Rate ◽  
Low Blood Pressure ◽  
Tract Disease ◽  
Hands And Feet

<strong>Objective:</strong> To discuss the application effect of high quality nursing service in the painless gastroscopy examination. <strong>Methods:</strong> Selected 132 cases of patients with gastrointestinal tract disease admitted by my hospital from May 2012 to May 2013 as the research object, 132 cases of patients with gastrointestinal tract disease were all given painless gastroscopy examination, clinically, all of them were given high quality nursing service. Observed and recorded nursing effect. <strong>Results:</strong> Among 132 cases of patients, there were 3 cases appeared untoward effect such as choking cough, respiratory depression, abdominal pain, low blood pressure and other adverse reactions, the adverse reaction rate was 2.27% (3/132); 0 cases of hospital infection; 132 cases all had side effects of propofol (dizzy giddy, hands and feet became limp, but no case of fell down; 131 patients were satisfied with high quality nursing service, the satisfaction rate was 99.2% (131/132). <strong>Conclusion:</strong> The application effect of high quality nursing service in painless gastroscopy examination was remarkable.

Clinical tolerance of single doses of ethionamide in patients with pulmonary tuberculosis

1982 ◽  
Vol 63 (4) ◽  
pp. 61-63
Author(s):  
G. A. Smirnov ◽  
L. T. Zamaletdinova ◽  
V. A. Mikhailovskaya ◽  
S. I. Latypova
Keyword(s):  
Single Dose ◽  
Gastrointestinal Tract ◽  
Side Effects ◽  
Pulmonary Tuberculosis ◽  
Chronic Diseases ◽  
Adverse Reactions ◽  
Number Of Patients

The tolerance of ethionamide was studied in 851 patients with pulmonary tuberculosis. The drug was administered at 0.75 g at a time. Side effects were noted in 31% of individuals, and complete intolerance - in 6.6%. For the rest, adverse reactions disappeared after a short break in taking the drug or when it was administered at night. In a number of patients, to remove side effects, it was necessary to reduce a single dose of ethionamide to 0.5 g or give it 0.25 g three times. More often, side complications occurred in persons with chronic diseases of the gastrointestinal tract, as well as in elderly and senile patients.

scholarly journals Comorbid patient with GERD and cardiovascular disease receiving antiplatelet therapy. The possibilities of choosing a proton pump inhibitor on a case study

2019 ◽  
pp. 10-16
Author(s):  
I. G. Pakhomova
Keyword(s):  
Cardiovascular Disease ◽  
Drug Therapy ◽  
Gastrointestinal Tract ◽  
Antiplatelet Therapy ◽  
Proton Pump ◽  
Adverse Reactions ◽  
Clinical Expertise ◽  
High Prevalence ◽  
Upper Gastrointestinal

The high prevalence of cardiovascular disease and its frequent pathogenetic relationship with various comorbid diseases and conditions lead to polypragmasia and the development of undesirable adverse reactions. Treatment premorbidly disorders requires high clinical expertise and breadth of knowledge in the field of related disciplines that allows you to efficiently prescribe the appropriate drug therapy. It is important to emphasize that a patient with cardiovascular disease often receives antiplatelet therapy, including double, which can lead to adverse reactions from the upper gastrointestinal tract (due to the peculiarities of the mechanism of action of antiplatelet drugs), including from the esophagus, provoking the development or deterioration of gastroesophageal reflux disease (GERD). Proton pump inhibitors (PPI) are used for the prevention and treatment of these adverse events on the part of the gastrointestinal tract. Effective drug therapy for GERD also includes the administration of these drugs. However. Given the polymorbidity of patients and polypragmasia, the practitioner should strive to prescribe drugs with the lowest risk of drug interactions. These requirements are met by PPI rabeprazole, the metabolism of which is predictable. The use of this drug is presented in a clinical case.

scholarly journals Uvangoletin induces mitochondria-mediated apoptosis in HL-60 cells in vitro and in vivo without adverse reactions of myelosuppression, leucopenia and gastrointestinal tract disturbances

2015 ◽  
Vol 35 (2) ◽  
pp. 1213-1221 ◽  
Author(s):  
ZHUANZHEN ZHENG ◽  
ZHENHUA QIAO ◽  
RONG GONG ◽  
YALIN WANG ◽  
YIQUN ZHANG ◽  
...  
Keyword(s):  
Gastrointestinal Tract ◽  
Adverse Reactions

Habitat Association of Klebsiella Species

1985 ◽  
Vol 6 (2) ◽  
pp. 52-58 ◽  
Author(s):  
Susan T. Bagley
Keyword(s):  
Drinking Water ◽  
Gastrointestinal Tract ◽  
Surface Waters ◽  
Industrial Effluents ◽  
Opportunistic Pathogen ◽  
Habitat Associations ◽  
Habitat Association ◽  
Klebsiella Species ◽  
Almost All ◽  
Polluted Waters

AbstractThe genus Klebsiella is seemingly ubiquitous in terms of its habitat associations. Klebsiella is a common opportunistic pathogen for humans and other animals, as well as being resident or transient flora (particularly in the gastrointestinal tract). Other habitats include sewage, drinking water, soils, surface waters, industrial effluents, and vegetation. Until recently, almost all these Klebsiella have been identified as one species, ie, K. pneumoniae. However, phenotypic and genotypic studies have shown that “K. pneumoniae” actually consists of at least four species, all with distinct characteristics and habitats. General habitat associations of Klebsiella species are as follows: K. pneumoniae—humans, animals, sewage, and polluted waters and soils; K. oxytoca—frequent association with most habitats; K. terrigena— unpolluted surface waters and soils, drinking water, and vegetation; K. planticola—sewage, polluted surface waters, soils, and vegetation; and K. ozaenae/K. rhinoscleromatis—infrequently detected (primarily with humans).

Keratinocyte growth factor binds to collagens of the gastrointestinal tract: Identification of the collagen binding structure

2001 ◽  
Vol 120 (5) ◽  
pp. A695-A695
Author(s):  
M RUEHL ◽  
I SCHOENFELDER ◽  
R FARNDALE ◽  
G KNIGHT ◽  
R SOMASUNDARAM ◽  
...  
Keyword(s):  
Gastrointestinal Tract ◽  
Growth Factor ◽  
Keratinocyte Growth Factor ◽  
Collagen Binding ◽  
Binding Structure

Culture Studies of the Gastrointestinal Tract with a Newly Devised Capsule

1963 ◽  
Vol 45 (5) ◽  
pp. 625-632 ◽  
Author(s):  
Margot Shiner ◽  
T.E. Waters ◽  
J.D. Allan Gray ◽  
R.A. Lambert
Keyword(s):  
Gastrointestinal Tract ◽  
Culture Studies

Evaluation of Oral Glutamate in Ammonemia Due to Blood in the Gastrointestinal Tract

1960 ◽  
Vol 39 (2) ◽  
pp. 191-195 ◽  
Author(s):  
Alice N. Bessman ◽  
George S. Mirick ◽  
Robert Hawkins
Keyword(s):  
Gastrointestinal Tract
Sign in / Sign up

Export Citation Format

Share Document